Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus
Research Question:
Does Ruxolitinib treatment work for discoid lupus?
Basic Study Information
Purpose:
The purpose of this study is to assess the potential beneficial effect of ruxolitinib
cream for the treatment of discoid lupus erythematosus. There are no creams specifically
FDA-approved for use in lupus and a great need exists for new treatments. Ruxolitinib
cream has been shown to be safe and effective in a number of other skin diseases such
as eczema, but has not been studied in discoid lupus. You are eligible if you are
18 years old or older, have a diagnosis of discoid lupus, and have at least one active
lesion on your skin.
Location: University of Rochester Medical Center
Study Reference #: STUDY00006186
Lead Researcher (Principal Investigator)
Lead Researcher:
Christopher Richardson
Study Contact Information
Study Coordinator: Michelle G. Smith
Phone: (585) 275-0374
Email: MichelleG_Smith@URMC.Rochester.edu
Additional Study Details
Study Details:
If you decide to take part in this study, you will be asked to apply ruxolitinib cream
to your lupus skin lesions twice a day for 12 weeks. You will also be asked to visit
the clinic a total of seven times for assessment of your treatment.
Number of Visits:
6 to 10
Reimbursement:
Yes
Trial Not Found
The study you are looking for is not active at this time.
Return to Search